The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Open accessAbstract
Exhausted CD8+ T (T ex) cells in chronic infections and cancer have limited effector function, high co-expression of inhibitory receptors and extensive transcriptional changes compared with effector (T eff) or memory (T mem) CD8+ T cells. T ex cells are important clinical targets of checkpoint blockade and other immunotherapies. Epigenetically, T ex cells are a distinct immune subset, with a unique chromatin landscape compared with T eff and T mem cells. However, the mechanisms that govern the transcriptional and epigenetic development of T ex cells remain unknown. Here we identify the HMG-box transcription factor TOX as a central regulator of T ex cells in mice. TOX is largely dispensable for the formation of T eff and T mem cells, but it is critical for exhaustion: in the absence of TOX, T ex cells do not form. TOX is induced by calcineurin and NFAT2, and operates in a feed-forward loop in which it becomes calcineurin-independent and sustained in T ex cells. Robust expression of TOX therefore results in commitment to T ex cells by translating persistent stimulation into a distinct T ex cell transcriptional and epigenetic developmental program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“CD8 T cells are typically regarded as a uniform population with cytotoxic function; however, recent studies have highlighted the diversity of the CD8 T-cell population (5)(6)(7)(8)(9).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“which transcriptionally and epigenetically programs CD8+ T cell exhaustion [52].”
From Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC (2025) · cites this paper as [52]
The cited source says what the claim attributes to it.
In the citing paper
“Treatment‐induced declines in PD‐1+ CD8 T cells are consistent with the possibility that thymus regeneration treatment epigenetically reprograms “exhausted” CD8 T cells (T EX), a recently characterized distinct PD‐1+ CD8 population (Khan et al., 2019).”
From Reversal of epigenetic aging and immunosenescent trends in humans. (2019) · cites this paper as Khan et al., 2019
In the citing paper
“The excessive antigen density and kinetics of antigen exposure in solid tumors can drive exhaustion or dysfunction of T cells (Khan et al., 2019; Wherry, 2011).”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Khan et al., 2019
In the citing paper
“Furthermore, bulk RNA-seq analysis of isolated cells (ND naïve, HFHC Tem, HFHC Trm, and RES Trm) revealed that both Trm subsets from HFHC mice and RES mice expressed core signature genes of Trm21–24 with exceptions including Itgae (CD103) and Eomes (Fig. 4d).”
From CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells (2021) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Self-citationMaster Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citationSuper-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Cited by
Sorted by citations
Items 401–500 of 1,001
New Insights into Epigenetic Regulation of T Cell Differentiation
Dutta, A., Venkataganesh, H., & Love, P. E. (2021) · Cells · doi:10.3390/cells10123459 · Cited by 52
Janelle, V., & Delisle, J. (2021) · Cancers · doi:10.3390/cancers13040598 · Cited by 52
Khanal, S., Schank, M., Gazzar, M. E., Moorman, J. P., & Yao, Z. Q. (2021) · Cells · doi:10.3390/cells10020475 · Cited by 47
Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma
Kim, A.-R., Choi, S. J., Park, J., Kwon, M., Chowdhury, T., Yu, H. J., Kim, S., Kang, H., Kim, K.-M., Park, S.-H., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2026019 · Cited by 48
Corría-Osorio, J., Carmona, S. J., Stefanidis, E., Andreatta, M., Ortiz-Miranda, Y., Muller, T., Rota, I. A., Crespo, I., Seijo, B., Castro, W., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01477-2 · Cited by 50
Im, S. J., Lee, K., & Ha, S. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01301-3 · Cited by 51
Wang, X., Xiao, T., Chen, P., Jiang, P., Li, W., Chang, H., Wei, C., Lai, X., Zhang, H., Pan, Y., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01986-y · Cited by 52
The epigenetic hallmarks of immune cells in cancer
Yu, J. H., Xiao, C., Fan, T. T., Deng, Z., Wang, D., Cai, W., Li, J., Liao, T., Li, C., & He, J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02255-4 · Cited by 52
Zhou, M., Sacirbegovic, F., Zhao, K., Rosenberger, S., & Shlomchik, W. D. (2020) · Nature Communications · doi:10.1038/s41467-020-17991-y · Cited by 48
Tumor endothelial cell‐induced CD8+ T‐cell exhaustion via GPNMB in hepatocellular carcinoma
Sakano, Y., Noda, T., Kobayashi, S., Sasaki, K., Iwagami, Y., Yamada, D., Tomimaru, Y., Akita, H., Gotoh, K., Takahashi, H., et al. (2022) · Cancer Science · doi:10.1111/cas.15331 · Cited by 46
Inflammatory signals are sufficient to elicit TOX expression in mouse and human CD8+ T cells
Maurice, N. J., Berner, J., Taber, A. K., Zehn, D., & Prlic, M. (2021) · JCI Insight · doi:10.1172/jci.insight.150744 · Cited by 47
Lin, S., Lu, J., Zhong, D., Song, M., Liu, J., You, W., Li, W.-H., Lin, L., Shi, D., & Chen, Y. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005902 · Cited by 48
Harber, J., Kamata, T., Pritchard, C. A., & Fennell, D. A. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003032 · Cited by 47
Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches
Gu, T., Zhu, M., Huang, H., & Hu, Y. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200256 · Cited by 45
Srivastava, N., Hu, H., Peterson, O. J., Vomund, A. N., Stremska, M. E., Zaman, M., Giri, S., Li, T., Lichti, C. F., Zakharov, P. N., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.017 · Cited by 50
Research progress in tumor angiogenesis and drug resistance in breast cancer
Mou, J., Li, C., Zheng, Q., Meng, X., & Tang, H. (2024) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0515 · Cited by 48
T cell dynamics with neoadjuvant immunotherapy in head and neck cancer
Zhao, M., Schoenfeld, J. D., Egloff, A. M., Hanna, G. J., Haddad, R. I., Adkins, D. R., & Uppaluri, R. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00969-w · Cited by 50
The Impact of Malaria Parasites on Dendritic Cell–T Cell Interaction
Osii, R., Otto, T. D., Garside, P., Ndungu, F. M., & Brewer, J. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01597 · Cited by 49
Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy
Nüssing, S., Trapani, J. A., & Parish, I. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.589641 · Cited by 48
Reversing T-cell exhaustion in immunotherapy: a review on current approaches and limitations
Tabana, Y., Moon, T. C., Siraki, A. G., Elahi, S., & Barakat, K. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1937123 · Cited by 47
Schrödinger’s T Cells: Molecular Insights Into Stemness and Exhaustion
Gonzalez, N. M., Zou, D., Gu, A., & Chen, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.725618 · Cited by 46
Bright future or blind alley? CAR-T cell therapy for solid tumors
Zhang, K., Chen, H., Li, F., Sheng, H., Chen, F., & Li, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1045024 · Cited by 48
T lymphocyte cell: A pivotal player in lung cancer
Wu, Y., Yuan, M., Wang, C., Chen, Y., Zhang, Y., & Zhang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1102778 · Cited by 48
Rossi, M., Vecchi, A. L., Tiezzi, C., Barili, V., Fisicaro, P., Penna, A., Montali, I., Daffis, S., Fletcher, S. P., Gaggar, A., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-327202 · Cited by 44
Bordon, Y. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0193-9 · Cited by 46
Regulation of PD-1 in T cells for cancer immunotherapy
Yu, X., Gao, R., Li, Y., & Zeng, C. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173240 · Cited by 45
Altered cancer metabolism and implications for next-generation CAR T-cell therapies
Ramapriyan, R., Vykunta, V. S., Vandecandelaere, G., Richardson, L. G., Sun, J. M., Curry, W. T., & Choi, B. D. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108667 · Cited by 48
Köhler, N., Ruess, D. A., Kesselring, R., & Zeiser, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.634435 · Cited by 45
T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective
Peters, F. S., Strefford, J. C., Eldering, E., & Kater, A. P. (2021) · Haematologica · doi:10.3324/haematol.2020.267914 · Cited by 43
Kim, M. J., & Ha, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.767466 · Cited by 46
Tertiary Lymphoid Structure Raises Survival and Immunotherapy in HPV − HNSCC
Li, H., Zhu, S., Zhou, J., Chen, D.-R., Liu, J., Zz, W., Wang, W., Zhang, M.-J., & Sun, Z. (2023) · Journal of Dental Research · doi:10.1177/00220345231151685 · Cited by 43
Neubert, E. N., DeRogatis, J. M., Lewis, S. A., Viramontes, K. M., Ortega, P., Henriquez, M. L., Buisson, R., Messaoudi, I., & Tinoco, R. (2023) · Nature Communications · doi:10.1038/s41467-023-41352-0 · Cited by 45
The malate shuttle detoxifies ammonia in exhausted T cells by producing 2-ketoglutarate
Weisshaar, N., Ma, S., Ming, Y., Madi, A., Mieg, A., Hering, M., Zettl, F., Möhr, K., ten Bosch, N., Stichling, D., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01636-5 · Cited by 43
Self-citationKaptein, P., Slingerland, N., Metoikidou, C., Prinz, F., Brokamp, S., Machuca-Ostos, M., de Roo, G., Schumacher, T. N., Yeung, Y. A., Moynihan, K. D., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1263 · Cited by 41
T cell exhaustion in human cancers
Kang, K., Lin, X., Chen, P., Liu, H., Liu, F., Xiong, W., Li, G., Yi, M., Li, X., Wang, H., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189162 · Cited by 49
Early methionine availability attenuates T cell exhaustion
Sharma, P., Guo, A., Poudel, S., Boada-Romero, E., Verbist, K., Palacios, G., Immadisetty, K., Chen, J., Haydar, D., Mishra, A., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02223-6 · Cited by 45
Single-Cell Analyses Identify Dysfunctional CD16+ CD8 T Cells in Smokers
Martos, S. N., Campbell, M. R., Lozoya, O. A., Wang, X., Bennett, B. D., Thompson, I. J. B., Wan, M., Pittman, G. S., & Bell, D. A. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100054 · Cited by 45
Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma
Brauneck, F., Weimer, P., Wiesch, J. S. Z., Weisel, K. C., Leypoldt, L. B., Vohwinkel, G., Fritzsche, B., Bokemeyer, C., Wellbrock, J., & Fiedler, W. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.763773 · Cited by 43
Epigenetic regulation of T cell adaptive immunity
Frias, A. B., Boi, S. K., Lan, X., & Youngblood, B. (2021) · Immunological Reviews · doi:10.1111/imr.12943 · Cited by 44
Complementarity-determining region clustering may cause CAR-T cell dysfunction
Sarén, T., Saronio, G., Torrell, P. M., Zhu, X., Thelander, J., Andersson, Y., Hofström, C., Nestor, M., Dimberg, A., Persson, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40303-z · Cited by 43
Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens
Schlabach, M. R., Lin, S., Collester, Z. R., Wrocklage, C., Shenker, S., Calnan, C., Xu, T., Gannon, H., Williams, L. J., Thompson, F., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163096 · Cited by 44
Common gamma chain cytokines and CD8 T cells in cancer
Shourian, M., Beltra, J., Bourdin, B., & Decaluwe, H. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101307 · Cited by 43
Martínez-Usatorre, A., Carmona, S. J., Godfroid, C., Maroun, C. Y., Labiano, S., & Romero, P. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00340 · Cited by 41
CRISPR screen in mechanism and target discovery for cancer immunotherapy
Liu, D., Zhao, X., Tang, A., Xu, X., Liu, S., Zha, L., Ma, W., Zheng, J., & Shi, M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188378 · Cited by 44
Self-citationMaschmeyer, P., Heinz, G. A., Skopnik, C. M., Lutter, L., Mazzoni, A., Heinrich, F., von Stuckrad, A. S. L., Wirth, L. E., Tran, C. L., Riedel, R., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048797 · Cited by 41
Snell, L. M., Xu, W., Abd-Rabbo, D., Boukhaled, G. M., Guo, M., MacLeod, B., Elsaesser, H. J., Hezaveh, K., Alsahafi, N., Lukhele, S., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-01060-7 · Cited by 40
Self-citationMancini, M., Righetto, M., & Noeßner, E. (2021) · Cancers · doi:10.3390/cancers13236016 · Cited by 43
Epigenetics and CD8+ T cell memory*
Montacchiesi, G., & Pace, L. (2021) · Immunological Reviews · doi:10.1111/imr.13057 · Cited by 43
Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control
Perdomo-Celis, F., Passaes, C., Monceaux, V., Volant, S., Boufassa, F., de Truchis, P., Marcou, M., Bourdic, K., Weiss, L., Jung, C., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157549 · Cited by 44
A variety of ‘exhausted’ T cells in the tumor microenvironment
Nagasaki, J., & Togashi, Y. (2022) · International Immunology · doi:10.1093/intimm/dxac013 · Cited by 43
Landscapes and mechanisms of CD8+ T cell exhaustion in gastrointestinal cancer
Ding, J., Yang, K., Zhou, H., Huang, Y.-F., Li, H., & Zong, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1149622 · Cited by 45
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Liu, Z., Xu, X., Liu, H., Zhao, X., Yang, C., & Fu, R. (2023) · Experimental Hematology & Oncology · doi:10.1186/s40164-023-00456-5 · Cited by 40
Self-citationLevin, N., Kim, S. P., Marquardt, C., Vale, N. R., Yu, Z., Sindiri, S., Gartner, J. J., Parkhurst, M. R., Krishna, S., Lowery, F. J., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008645 · Cited by 42
Pileri, A., Guglielmo, A., Grandi, V., Violetti, S. A., Fanoni, D., Fava, P., Agostinelli, C., Berti, E., Quaglino, P., & Pimpinelli, N. (2021) · Cells · doi:10.3390/cells10102780 · Cited by 42
Tracy, S. I., Venkatesh, H., Hekim, C., Heltemes-Harris, L. M., Knutson, T. P., Bachanová, V., & Farrar, M. A. (2022) · Blood · doi:10.1182/blood.2021015341 · Cited by 41
Huang, Y., Xie, Y., Zhang, Y., Liu, Z., Jiang, W., Ye, Y., Tang, J., Li, Z., Yin, Z., & Lin, X.-J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02370-2 · Cited by 41
How metabolism bridles cytotoxic CD8+ T cells through epigenetic modifications
Acker, H. H. V., Ma, S., Scolaro, T., Kaech, S. M., & Mazzone, M. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.03.006 · Cited by 39
LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice
Mulholland, M., Kritikou, E., Katra, P., Nilsson, J., Björkbacka, H., Lichtman, A. H., Rodríguez, A., & Engelbertsen, D. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.09.005 · Cited by 39
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
Ali, L. R., Garrido-Castro, A. C., Lenehan, P. J., Böllenrücher, N., Stump, C. T., Dougan, M. L., Goel, S., Shapiro, G. I., Tolaney, S. M., & Dougan, S. K. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20220729 · Cited by 40
The Interplay between T Cells and Cancer: The Basis of Immunotherapy
Chen, C., Liu, X., Chang, C., Wang, H. Y., & Wang, R. (2023) · Genes · doi:10.3390/genes14051008 · Cited by 42
Pan, B., Chen, Z., Zhang, X., Wang, Z., Yao, Y., Wu, X., Qiu, J., Lin, H., Yu, L., Tu, H., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006817 · Cited by 41
Sun, R., Lei, C., Xu, Z., Gu, X., Huang, L., Chen, L., Tan, Y., Peng, M., Yaddanapudi, K., Siskind, L. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45084-7 · Cited by 43
Ren, F., Wang, L., Wang, Y., Wang, J., Wang, Y., Song, X., Zhang, G., Nie, F., & Lin, S. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06960-8 · Cited by 46
Recruit or Reboot? How Does Anti-PD-1 Therapy Change Tumor-Infiltrating Lymphocytes?
Callahan, M. K., & Wolchok, J. D. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.08.009 · Cited by 41
Renaude, E., Kroemer, M., Loyon, R., Binda, D., Borg, C., Boyer‐Guittaut, M., Hervouet, É., & Peixoto, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051673 · Cited by 42
Adaptive Immune Response against Hepatitis C Virus
Kemming, J. S., Thimme, R., & Neumann‐Haefelin, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165644 · Cited by 40
TCF-1 maintains CD8+ T cell stemness in tumor microenvironment
Wen, S., Lu, H., Wang, D., Guo, J., Dai, W., & Wang, Z. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr1120-778r · Cited by 43
Rogers, D., Sood, A., Wang, H., van Beek, J. J. P., Rademaker, T. J., Artusa, P., Schneider, C., Shen, C., Wong, D. C., Bhagrath, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110064 · Cited by 39
The cellular and molecular basis of CD69 function in anti-tumor immunity
Koyama‐Nasu, R., Wang, Y., Hasegawa, I., Endo, Y., Nakayama, T., & Kimura, M. Y. (2022) · International Immunology · doi:10.1093/intimm/dxac024 · Cited by 44
Advancing beyond the twists and turns of T cell exhaustion in cancer
van der Heide, V., Humblin, É., Vaidya, A. B., & Kamphorst, A. O. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo4997 · Cited by 41
Lv, J., Qin, L., Zhao, R., Wu, D., Wu, Z., Zheng, D., Li, S., Luo, M., Wu, Q., Long, Y., et al. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.12.003 · Cited by 38
Senjo, H., Harada, S., Kubota, S. I., Tanaka, Y., Tateno, T., Zhang, Z., Okada, S., Chen, X., Kikuchi, R., Miyashita, N., et al. (2023) · Blood · doi:10.1182/blood.2023019875 · Cited by 41
CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8+ T cells via JAK2/STAT3 pathway
Cao, C., Xu, M., Ye, W., Peng, T., Lin, S., Liu, X., Xu, Y., Chu, T., Liu, S., Wu, P., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100659 · Cited by 39
Sawada, M., Goto, K., Morimoto-Okazawa, A., Haruna, M., Yamamoto, K., Yamamoto, Y., Nakagawa, S., Hiramatsu, K., Matsuzaki, S., Kobayashi, E., et al. (2020) · International Immunology · doi:10.1093/intimm/dxaa010 · Cited by 41
T-cell Exhaustion in Organ Transplantation
Angeletti, A., Cantarelli, C., Riella, L. V., Fribourg, M., & Cravedi, P. (2021) · Transplantation · doi:10.1097/tp.0000000000003851 · Cited by 39
Ding, J. P., Guyette, S., Schrand, B., Geirut, J., Horton, H. M., Guo, G., Delgoffe, G. M., Menk, A. V., Baeuerle, P. A., Hofmeister, R., et al. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2182058 · Cited by 35
Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas
Blanco-Carmona, E., Narayanan, A., Hernandez, I., Nieto, J. C., Elosua-Bayés, M., Sun, X., Schmidt, C., Pamir, M. N., Özduman, K., Herold‐Mende, C. C., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101249 · Cited by 43
Zhou, W., Kawashima, S., Ishino, T., Kawase, K., Ueda, Y., Yamashita, K., Watanabe, T., Kawazu, M., Dansako, H., Suzuki, Y., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113797 · Cited by 38
Dimitri, A. J., Baxter, A. E., Chen, G. M., Hopkins, C. R., Rouin, G. T., Huang, H., Kong, W., Holliday, C., Wiebking, V., Bartoszek, R. L., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp9371 · Cited by 42
Self-citationAdvances in LAG3 cancer immunotherapeutics
Adam, K. R., Butler, S. C., Workman, C. J., & Vignali, D. A. A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.10.009 · Cited by 37
Deschler, S., Pohl, J., Ramsauer, L., Meiser, P., Erlacher, S., Schenk, R. P., Maurer, H. C., Shen, P., Kager, J., Zink, J., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.06.006 · Cited by 41
Harnessing the IL-21-BATF Pathway in the CD8+ T Cell Anti-Tumor Response
Topchyan, P., Xin, G., Chen, Y., Zheng, S., Burns, R., Shen, J., Kasmani, M. Y., Kudek, M. R., Yang, N., & Cui, W. (2021) · Cancers · doi:10.3390/cancers13061263 · Cited by 39
Immunotherapeutic Potential of T Memory Stem Cells
Li, Y., Wu, D., Yang, X., & Zhou, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.723888 · Cited by 37
Hope, J. L., Otero, D. C., Bae, E., Stairiker, C. J., Palete, A. B., Faso, H. A., Lin, M. P., Henriquez, M. L., Roy, S. B., Seo, H., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112436 · Cited by 39
Hall, M. S., Teer, J. K., Yu, X., Branthoover, H., Snedal, S. A., Rodríguez-Valentín, M., Nagle, L., Scott, E. N., Schachner, B. I., Innamarato, P., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007288 · Cited by 39
Reversal of Immunity After Clearance of Chronic HCV Infection—All Reset?
Wedemeyer, H. H., Khera, T., Strunz, B., & Björkström, N. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571166 · Cited by 36
Vorwald, V. M., Davis, D. M., Gulick, R. J. V., Torphy, R. J., Borgers, J. S. W., Klarquist, J. S., Couts, K. L., Amato, C. M., Cogswell, D. T., Fujita, M., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1367 · Cited by 34
Long-term caloric restriction ameliorates T cell immunosenescence in mice
Asami, T., Endo, K., Matsui, R., Sawa, T., Tanaka, Y., Saiki, T., Tanba, N., Haga, H., & Tanaka, S. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111710 · Cited by 37
Romine, K. A., MacPherson, K., Cho, H.-J., Kosaka, Y., Flynn, P., Byrd, K., Coy, J. L., Newman, M., Pandita, R., Loo, C. P., et al. (2023) · Leukemia · doi:10.1038/s41375-023-01808-0 · Cited by 35
The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer
Zhang, J., Lei, F., & Tan, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166128 · Cited by 39
Rapid recruitment and IFN-I–mediated activation of monocytes dictate focal radiotherapy efficacy
Tadepalli, S., Clements, D. R., Saravanan, S., Hornero, R. A., Lüdtke, A., Blackmore, B., Paulo, J. A., Gottfried‐Blackmore, A., Seong, D., Park, S., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.add7446 · Cited by 39
Grayson, J. M., Short, S. M., Lee, C.-J., Park, N., Marsac, C., Sette, A., Arlehamn, C. S. L., Leng, X., Lockhart, S. N., & Craft, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-42708-8 · Cited by 42
Lin, S., Sun, Y., Cao, C., Zhu, Z., Xu, Y., Liu, B., Hu, B., Peng, T., Zhi, W., Xu, M., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104846 · Cited by 38
Zhang, H., Luo, X.-J., Yang, W., Wu, Z., Zhao, Z., Pei, X., Zhang, X., Chen, C., Lei, J. H., Shi, Q., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53997-6 · Cited by 37
Unlocking the potential of engineered immune cell therapy for solid tumors
Albarrán, V., Angelats, L., Delgado, J., Gros, A., Urbano-Ispizúa, Á., Guedan, S., & Prat, A. (2025) · Nature Communications · doi:10.1038/s41467-025-56527-0 · Cited by 39
Hope, J. L., Stairiker, C. J., Bae, E., Otero, D. C., & Bradley, L. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01595 · Cited by 38
A Human In Vitro T Cell Exhaustion Model for Assessing Immuno-Oncology Therapies
Dunsford, L. S., Thoirs, R. H., Rathbone, E. J., & Patakas, A. (2020) · Methods in pharmacology and toxicology · doi:10.1007/978-1-0716-0171-6_6 · Cited by 34
Burrack, A. L., Rollins, M. R., Spartz, E. J., Mesojednik, T. D., Schmiechen, Z. C., Raynor, J. F., Wang, I., Kedl, R. M., & Stromnes, I. M. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000765 · Cited by 33
Kumar, D., Prince, C. Z., Bennett, C. M., Briones, M. A., Lucas, L., Russell, A. L., Patel, K. P., Chonat, S., Graciaa, S. H., Edington, H. J., et al. (2021) · Blood · doi:10.1182/blood.2021012924 · Cited by 36
Self-citationWong, W., Yin, B., Lam, C. Y. K., Huang, Y., Yan, J., Tan, Z., & Wong, S. H. D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.783227 · Cited by 35
Metadata
- Authors
- Khan, O., Giles, J. R., McDonald, S., Manne, S., Ngiow, S. F., Patel, K. P., Werner, M. T., Huang, A. C., Alexander, K. A., Wu, J. E., Attanasio, J., Yan, P., George, S. M., Bengsch, B., Staupe, R. P., Donahue, G., Xu, W., Amaravadi, R. K., Xu, X., Karakousis, G. C., Mitchell, T. C., Schuchter, L. M., Kaye, J., Berger, S. L., & Wherry, E. J.
- Affiliations
- Arsenal Biosciences (United States) (US)
- University of Pennsylvania (US)
- University of Freiburg (DE)
- Abramson Cancer Center (US)
- Cedars-Sinai Medical Center (US)
- Parker Institute for Cancer Immunotherapy (US)
- Corresponding author
- Wherry, E. John
- ORCID
- Khan, Omar
- Giles, Josephine R.
- McDonald, Sierra
- Manne, Sasikanth
- Ngiow, Shin Foong
- Patel, Kunal P.
- Werner, Michael T.
- Huang, Alexander C.
- Alexander, Katherine A.
- Wu, Jennifer E.
- Attanasio, John
- Yan, Patrick
- Bengsch, Bertram
- Staupe, Ryan P.
- Donahue, Greg
- Xu, Wei
- Amaravadi, Ravi K.
- Xu, Xiaowei
- Karakousis, Giorgos C.
- Mitchell, Tara C.
- Schuchter, Lynn M.
- Kaye, Jonathan
- Berger, Shelley L.
- Wherry, E. John
- Venue
- Nature
- Published
- 2019-06-17
- Volume
- 571
- Issue
- 7764
- Pages
- 211-218
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6713202
- OpenAlex
- W2952815301
- Cited by
- 1,646
- References
- 63
- Citations by year
- 2026: 258 · 2025: 249 · 2024: 234 · 2023: 252 · 2022: 211 · 2021: 235 · 2020: 161 · 2019: 43
- FWCI
- 64.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA078831, F32CA221010, P30CA010815, P01CA210944)
- National Institute of Allergy and Infectious Diseases (R01AI115712, R01AI054977, R01AI105343, F30AI129263, U19AI117950, U19AI082630, P01AI108545)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- TOX transcription factor, CD8+ T cell exhaustion, chromatin landscape, epigenetic regulation, calcineurin, NFATc1, feed-forward loop, inhibitory receptors, chronic infection, cancer immunotherapy, checkpoint blockade, transcriptional programs
- MeSH terms
- Animals, Epistasis, Genetic, Female, Gene Expression Regulation, Genotype, Immunologic Memory, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Transcription, Genetic, Homeodomain Proteins, CD8-Positive T-Lymphocytes, Tumor Escape, Calcineurin, Calcium Signaling, Feedback, Physiological, NFATC Transcription Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
